Honeywell inks China packaging deal

By Nick Taylor

- Last updated on GMT

Honeywell has entered into a three-year agreement to supply its Aclar brand moisture-barrier films to Shanghai Haishun Packaging Material.

The deal grants Honeywell increased access to the rapidly expanding packaging market, which was worth $2.4bn in 2007 according to FriedlNet and Partners​.

In turn Haishun gains access to Aclar to improve the quality of its products and will also receive technical services and training from Honeywell.

Weir Lin, general manager of Haishun, said: "Honeywell has years of experience in technology innovation and offers market advantages in the area of specialty films​.

"Our agreement with Honeywell will upgrade the technology and quality level of our products, and allow us to promote new moisture-barrier packing materials to pharmaceutical manufacturers in China​."

Honeywell promotes Aclar as being clear, chemical-resistant, non-flammable, biochemically inert and free from plasticisers and stabilisers. These traits are coupled to its effectiveness as a moisture barrier.

Aclar has been used in a range of applications from blister packaging to overwraps and pouches, with the products flexible variant proving particular suitable for the latter uses.

Like many other companies Honeywell has been trying to establish a presence in China and Asia-Pacific, with the opening of its technology centre in Shanghai intended to achieve this.

However, Haishun will receive Aclar that has been manufactured at Honeywell’s plant in Pottsville, Pennsylvania.

Related news

Show more

Related products

Solution for challenging antibodies – Planova™ S20N

Solution for challenging antibodies – Planova™ S20N

Content provided by Asahi Kasei Medical Co., Ltd. | 24-Sep-2024 | White Paper

Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration performance for challenging molecules...

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us

Products

View more

Webinars